Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Research groups

College



Olivier Zanier

MMed


DPhil student

Research

I investigate novel treatment agents for paediatric high-grade gliomas (pHGG), highly aggressive brain tumours in children for which very limited therapeutic options exist. My work focuses on exploring drugs that induce reactive oxygen species (ROS) as well as a hypoxia-activated HDAC inhibitor, particularly in combination with radiotherapy and under hypoxic conditions - a key feature of the tumour microenvironment.

My research is supervised by Prof Hammond and Dr Olcina. It is part of HIT-GLIOan international consortium of researchers dedicated to enhancing the quality of life for pHGG patients and their families.

My studies are generously supported by the University of Oxford through a Clarendon Fund Scholarship and a Medical Sciences Postgraduate Studentship.

Biography

Before moving to Oxford, I studied medicine at the University of Zurich in Switzerland, where my research as part of the MICN-Lab focused on the intersection of neurosurgery and machine learning. As a physician-scientist, I aim to bridge the gap between research and clinical application with the goal of ultimately advancing patient care for neuro-oncological patients.